Chandan Basho
First SEC filing: Sept. 30, 2022 · Latest: Sept. 30, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 5, 2026 | ASTH | F | 1,790 | $38.47 | $68,861 | 157,820 Direct | -1.12% | Disposed | -6.7% (price as of 2026-10-02) |
| May 16, 2026 | ASTH | F | 8,155 | $38.26 | $312,010 | 159,610 Direct | -4.86% | Disposed | -6.2% (price as of 2026-10-02) |
| April 14, 2026 | ASTH | F | 3,870 | $29.07 | $112,501 | 167,765 Direct | -2.25% | Disposed | 23.4% (price as of 2026-10-02) |
| April 2, 2026 | ASTH | F | 2,092 | $25.05 | $52,405 | 171,635 Direct | -1.20% | Disposed | 43.2% (price as of 2026-10-02) |
| March 5, 2026 | ASTH | F | 1,240 | $25.07 | $31,087 | 173,727 Direct | -0.71% | Disposed | 43.1% (price as of 2026-10-02) |
| Oct. 2, 2025 | ASTH | F | 1,979 | $27.77 | $54,957 | 174,967 Direct | -1.12% | Disposed | 29.2% (price as of 2026-10-02) |
| Sept. 5, 2025 | ASTH | F | 1,694 | $29.70 | $50,312 | 176,946 Direct | -0.95% | Disposed | 20.8% (price as of 2026-10-02) |
| May 16, 2025 | ASTH | F | 10,035 | $27.18 | $272,751 | 178,640 Direct | -5.32% | Disposed | 32.0% (price as of 2026-10-02) |
| April 14, 2025 | ASTH | F | 2,683 | $34.05 | $91,356 | 188,675 Direct | -1.40% | Disposed | 5.4% (price as of 2026-10-02) |
| April 2, 2025 | ASTH | F | 1,394 | $30.02 | $41,848 | 191,358 Direct | -0.72% | Disposed | 19.5% (price as of 2026-10-02) |
| March 5, 2025 | ASTH | A | 26,701 | · | · | 192,752 Direct | +16.08% | Acquired | (price as of 2026-10-02) |
| Nov. 8, 2024 | ASTH | F | 691 | $46.96 | $32,449 | 166,051 Direct | -0.41% | Disposed | -23.6% (price as of 2026-10-02) |
| Nov. 8, 2024 | ASTH | A | 15,510 | · | · | 166,742 Direct | +10.26% | Acquired | (price as of 2026-10-02) |
| May 16, 2024 | ASTH | F | 7,051 | $41.13 | $290,008 | 151,232 Direct | -4.45% | Disposed | -12.8% (price as of 2026-10-02) |
| April 14, 2024 | ASTH | F | 7,993 | $40.72 | $325,475 | 158,283 Direct | -4.81% | Disposed | -11.9% (price as of 2026-10-02) |
| April 2, 2024 | ASTH | A | 15,692 | · | · | 172,783 Direct | +9.99% | Acquired | (price as of 2026-10-02) |
| March 29, 2024 | ASTH | F | 6,507 | $41.99 | $273,229 | 166,276 Direct | -3.77% | Disposed | -14.6% (price as of 2026-10-02) |
| May 16, 2023 | ASTH | A | 60,803 | · | · | 157,091 Direct | +63.15% | Acquired | (price as of 2026-10-02) |
| May 16, 2023 | ASTH | A | 60,808 | · | · | 96,288 Direct | +171.39% | Acquired | (price as of 2026-10-02) |
| May 16, 2023 | ASTH | A | 9,121 | · | · | 35,480 Direct | +34.60% | Acquired | (price as of 2026-10-02) |
| May 16, 2023 | ASTH | D | 48,086 | · | · | 26,359 Direct | -64.59% | Disposed | (price as of 2026-10-02) |
| May 16, 2023 | ASTH | A | 130,732 | · | · | 207,671 Direct | +169.92% | Acquired | (price as of 2026-10-02) |
| April 14, 2023 | ASTH | F | 2,494 | $39.06 | $97,416 | 74,445 Direct | -3.24% | Disposed | -8.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $678,077 | · | $2,199,997 | · | $979,891 | · | $9,092 | $3,867,057 |
| 2024 | $556,154 | · | $4,207,116 | · | $688,229 | · | $8,991 | $5,460,490 |
| 2022 | $195,000 | $385,000 | $3,308,377 | $213,431 | · | · | $1,419 | $4,103,227 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.